Product

Saline

Aliases
0.9% Saline, 0.9% sodium chloride, 0.9% (w/v) saline, normal Saline, Normal saline (18 other aliases)
Name
saline placebo

129 clinical trials

187 indications

Indication
COVID-19
Indication
Virus Diseases
Indication
Skin Wound
Indication
Abdominal Wound
Indication
cancer
Indication
Hepatocellular
Indication
Arthritis
Indication
Pain
Indication
Lung Cancer
Indication
Redness
Indication
Osteoarthritis
Indication
Influenza
Indication
Pandemic
Indication
Bunions
Indication
Healthy
Indication
HIV Infections
Indication
Dyslipidemia
Indication
rLP2086
Indication
Repevax
Indication
Meningitis
Indication
Healthy Subject
Indication
Rare Diseases
Indication
Leiomyoma
Indication
Sepsis
Indication
Anaemia
Indication
Iron-deficiency
Indication
Heart Failure
Indication
morbidity
Indication
PAIS
Indication
Neonatal Stroke
Indication
Healthy Aging
Indication
Sarcopenia
Indication
Hypogonadism
Indication
Dexmedetomidine
Indication
Suicide
Indication
Attempted
Indication
Brain Death
Indication
Anesthesia
Indication
Local
Indication
Vasoplegia
Indication
Menstruation
Indication
Type 2 Diabetes
Indication
Iron Deficiency
Indication
Postoperative
Indication
Premature Baby
Indication
Opioid Use
Indication
Ovarian Cancer
Indication
Rhinitis
Indication
Allergy
Indication
seasonal
Indication
Asthma
Indication
Mammaplasty
Indication
Norepinephrine
Indication
Glypressin
Indication
Meniscus Tear
Indication
Polytrauma
Indication
Glioblastoma
Indication
Astrocytoma
Indication
Grade IV
Indication
Dexamethasone
Indication
Hip Dysplasia
Indication
Pain Management
Indication
Cardiac Arrest
Indication
Out-Of-Hospital
Indication
Overdose
Indication
Naloxone
Indication
Fibromyalgia
Indication
Tranexamic Acid
Indication
Jaw Surgery
Indication
Edema
Indication
Bleeding
Indication
Arthroplasty
Indication
Replacement
Indication
hip
Indication
Alopecia Areata
Indication
Ankle Fusion
Indication
Fracture
Indication
Morphine
Indication
Analgesics
Indication
Opioid
Indication
Aging
Indication
Safety Issues
Indication
Tolerance
Indication
Uterine
Indication
Scar
Indication
Scarring
Indication
Hypertrophic
Indication
Obesity
Indication
Hypertension
Indication
Down syndrome
Indication
Breast Cancer
Indication
Burns
Indication
Type 1
Indication
Type 1 Diabetes
Indication
Stroke
Indication
Epicondylitis
Indication
Lateral
Indication
Type I
Indication
SARS-CoV-2
Indication
MPS II
Indication
Heart disease
Indication
Skin diseases
Indication
Hot Flashes
Indication
Hot Flushes
Clinical trial
Skin Prick Test of KeraStat® Cream
Status: Completed, Estimated PCD: 2019-08-02
Clinical trial
Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?
Status: Not yet recruiting, Estimated PCD: 2025-07-30
Clinical trial
Angiotensin II in Liver Transplantation (AngLT-1): A Pilot Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Postoperative Pain Control & Relief in Neonates
Status: Terminated, Estimated PCD: 2024-03-07
Clinical trial
In-office Repair of Chronic Tympanic Membrane Perforations
Status: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
Protective Effects of Angiotensin-(1-7) in Peripheral Arterial Disease
Status: Terminated, Estimated PCD: 2020-03-09
Clinical trial
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
Status: Not yet recruiting, Estimated PCD: 2028-12-31
Clinical trial
Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain
Status: Terminated, Estimated PCD: 2022-05-09
Clinical trial
Neural Response to Inflammatory Challenge in Major Depressive Disorder
Status: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
Status: Withdrawn, Estimated PCD: 2022-06-30
Clinical trial
Angiotensin-(1-7) Cardiovascular Effects in Aging
Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
FC-12738 Single Ascending Dose in Health Adult and Patients With ALS
Status: Recruiting, Estimated PCD: 2024-05-03
Clinical trial
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome
Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Cardiovascular Effects of Angiotensin 1-7 in Obesity Hypertension
Status: Terminated, Estimated PCD: 2023-05-03
Clinical trial
Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II
Status: Completed, Estimated PCD: 2020-10-30
Clinical trial
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
Status: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries: A Randomized Clinical Trial
Status: Active (not recruiting), Estimated PCD: 2024-05-30
Clinical trial
Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)
Status: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial
Status: Recruiting, Estimated PCD: 2025-05-30
Clinical trial
The Suppression of Toll Like Receptors by Insulin
Status: Completed, Estimated PCD: 2013-09-01
Clinical trial
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Status: Active (not recruiting), Estimated PCD: 2029-07-01
Clinical trial
Pharmacogenomics of GLP1 Receptor Agonists
Status: Terminated, Estimated PCD: 2018-11-30
Clinical trial
The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence
Status: Completed, Estimated PCD: 2021-07-26
Clinical trial
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers
Status: Completed, Estimated PCD: 2012-08-01
Clinical trial
The Effects of Low Dose Ketamine on Cardiovascular Function
Status: Terminated, Estimated PCD: 2021-05-28
Clinical trial
Stellate Ganglion Blockade for the Management of Vasomotor Symptoms
Status: , Estimated PCD: 2026-03-30